Add to ORKGPosterTo evaluate the performance characteristics of the Versant ? HBV DNA 3.0 assay (bDNA)+ (Versant, Bayer Healthcare LLC, Tarrytown, NY). 2.) To compare the Versant assay to the COBAS HBV TaqMan Analyte Specific Reagent assay (TaqMan) (Roche Molecular Systems, Pleasanton, CA) using random and defined patient populations
The optimal hepatitis B virus (HBV) DNA quantitative assay for clinical use remains to be determined...
Postererformance characteristics of the COBAS HBV TaqMan ASR (TaqMan) assay were evaluated and compa...
International audienceHepatitis B virus (HBV) DNA quantification is used to establish the prognosis ...
International audienceThe quantitation of human hepatitis B virus (HBV) in the serum of infected pat...
With an estimated 350–400 million people worldwide chronically infected with hepatitis B virus (HBV)...
Two tests for measurements of hepatitis B virus DNA in human serum and plasma, VERSANT HBV 3.0 (base...
BACKGROUND-AIMHepatitis B virus (HBV) is a major global health problem affecting more than 250 milli...
The performance characteristics of four different assays for hepatitis B virus (HBV) quantification ...
International audienceDetection and quantification of HBV DNA are essential to diagnose chronic HBV ...
Background. Over 240 million people are chronically infected with hepatitis B virus (HBV), the leadi...
AIM: To compare the performance of the Da-an real-time hepatitis B virus (HBV) DNA assay and Abbott ...
BACKGROUND: Hepatitis B virus DNA quantification is essential for managing chronic hepatitis B (CHB)...
International audienceBackground: Accurate molecular methods to detect and quantify hepatitis B viru...
International audienceQuantification of HBV DNA is used for initiating and monitoring antiviral trea...
The purpose of this study is to evaluate the usefulness of the new real-time PCR COBAS TaqMan 48 ana...
The optimal hepatitis B virus (HBV) DNA quantitative assay for clinical use remains to be determined...
Postererformance characteristics of the COBAS HBV TaqMan ASR (TaqMan) assay were evaluated and compa...
International audienceHepatitis B virus (HBV) DNA quantification is used to establish the prognosis ...
International audienceThe quantitation of human hepatitis B virus (HBV) in the serum of infected pat...
With an estimated 350–400 million people worldwide chronically infected with hepatitis B virus (HBV)...
Two tests for measurements of hepatitis B virus DNA in human serum and plasma, VERSANT HBV 3.0 (base...
BACKGROUND-AIMHepatitis B virus (HBV) is a major global health problem affecting more than 250 milli...
The performance characteristics of four different assays for hepatitis B virus (HBV) quantification ...
International audienceDetection and quantification of HBV DNA are essential to diagnose chronic HBV ...
Background. Over 240 million people are chronically infected with hepatitis B virus (HBV), the leadi...
AIM: To compare the performance of the Da-an real-time hepatitis B virus (HBV) DNA assay and Abbott ...
BACKGROUND: Hepatitis B virus DNA quantification is essential for managing chronic hepatitis B (CHB)...
International audienceBackground: Accurate molecular methods to detect and quantify hepatitis B viru...
International audienceQuantification of HBV DNA is used for initiating and monitoring antiviral trea...
The purpose of this study is to evaluate the usefulness of the new real-time PCR COBAS TaqMan 48 ana...
The optimal hepatitis B virus (HBV) DNA quantitative assay for clinical use remains to be determined...
Postererformance characteristics of the COBAS HBV TaqMan ASR (TaqMan) assay were evaluated and compa...
International audienceHepatitis B virus (HBV) DNA quantification is used to establish the prognosis ...